Hong Kong Stock Exchange · Healthcare
Invest in Sichuan Neautus Traditional Chinese Medicine stock from India
Indian and foreign residents can buy Sichuan Neautus Traditional Chinese Medicine (2206) shares directly through Paasa.
By Paasa · Updated
Sichuan Neautus Traditional Chinese Medicine at a glance
- Price
- HK$73.70-HK$13.30 (15.29%)
- Market cap
- HK$4.32B
- Day range
- HK$73.70 – HK$87.80
- P/E
- 49.15
- Dividend yield
- None
- Volume
- 399.22K
How to invest in Sichuan Neautus Traditional Chinese Medicine from India
Step 1
Open your Paasa account
KYC takes a few minutes: PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Step 2
Add funds from your Indian bank account
Remit up to $250,000 a year under the RBI's Liberalised Remittance Scheme. Your bank converts the rupees to US dollars at its rate on the day you remit, and Interactive Brokers converts the dollars to HKD when you buy.
Step 3
Search 2206 and buy
Find Sichuan Neautus Traditional Chinese Medicine by name or by its ticker, 2206, and place your order. Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share.
Why invest in Sichuan Neautus Traditional Chinese Medicine from India
What Sichuan Neautus Traditional Chinese Medicine does
Sichuan Neautus Traditional Chinese Medicine Co., Ltd. engages in the research and development, production, and sale of traditional Chinese medicine decoction-ready products. The company offers toxic decoction-ready medicines, including rhizoma pinelliae preparatum, ginger processed pinelliae, rhizoma pinelliae preparate, white aconitum carmichaelii, and black aconitum carmichaelii products; non-toxic decoction-ready medicines, such as Fritillaria cirrhosa, Dwarf lilyturf, Astragalus, Stir-fried Ziziphi spinosae semen, Coptis root, and Angelica sinensis. Sichuan Neautus Traditional Chinese Medicine operates in the Medical - Pharmaceuticals industry within the Healthcare sector.
Paasa handles the paperwork
Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.
Frequently asked questions
Can I buy Sichuan Neautus Traditional Chinese Medicine stock from India?
Yes. Indian residents and NRIs can buy Sichuan Neautus Traditional Chinese Medicine (2206) shares directly through Paasa. Sichuan Neautus Traditional Chinese Medicine is listed on the Hong Kong Stock Exchange, in the Medical - Pharmaceuticals industry. Your money leaves India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name at Interactive Brokers.
Do I need to buy a full Sichuan Neautus Traditional Chinese Medicine share?
Usually more than one, and not a fraction: many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share. At HK$73.70 a share, size the order by the lot, not by the share.
How are Sichuan Neautus Traditional Chinese Medicine dividends taxed for Indian investors?
Sichuan Neautus Traditional Chinese Medicine trades on the Hong Kong Stock Exchange but is domiciled in China, so any withholding on its dividends follows that country's rules rather than those of Hong Kong. Dividends are taxed at your slab rate in India. Paasa's dividend report shows the gross amount and any tax withheld for each payment.
What tax do I pay in India when I sell Sichuan Neautus Traditional Chinese Medicine shares?
Hong Kong generally does not levy capital gains tax on non-resident individual investors for HKEX-listed stocks. In India, gains on shares held for more than 24 months are long-term and taxed at 12.5%, and gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the HKD/INR rate on the day you bought and the day you sold, so the currency move is part of the gain. Paasa's capital-gains statement gives you the figures for your return.